Insulin Sensitivity, Binding, and Kinetics in Pancreatogenic and Type I Diabetes
The DOI matches its Crossref record.
Abstract
Pancreatogenic diabetes (PD), secondary either to chronic calcific pancreatitis or to pancreatectomy, is characterized by higher frequency of hypoglycemic events during insulin therapy in comparison with type I insulin-dependent diabetes (IDD). Not only glucagon deficiency, but an enhanced peripheral tissue sensitivity to insulin could account for this metabolic behavior. We investigated several facets of insulin action, e.g., tissue sensitivity to insulin, insulin binding to red cells, and insulin kinetics in seven patients with PD in comparison with type I. Tissue sensitivity to insulin was evaluated by means of the glucose-insulin clamp technique as M/I × 100 ratio (mg · kg ·−1 min−1/μU · ml−1), where M is the amount of glucose infused by Biostator GCIIS to clamp BG at basal level and I is the free insulin plateau concentration achieved by a primed-constant insulin infusion. At high BG 15 h after the last injection of regular insulin M/I × 100 was 7.79 (range 4.25–9.75) in PD and 4.20 (range 1.20–6.91) in D (P < 0.05). At low and equal BG M/I × 100 was 8.55 (range 6.35–9.72) in PD and 3.42 (range 1.19–6.75) in D (P < 0.01). The rate of endogenous glucose production was nearly totally suppressed in both groups of patients. Just before the two clamps, 125I-insulin specific binding to red cells was studied. The maximum specific binding was significantly higher in PD than in D at high BG (10.7 ± 1.7 vs. 7.4 ± 0.8/109 red cells) and at low and equal BG (12.4 ± 1.2 vs. 6.8 ± 0.8). Receptor concentration also was significantly higher in PD thant in D (P < 0.02) while no significant differences were found in high affinity (K̄e). Insulin kinetic data were analysed by using both “Model independent” (or noncompartmental) method and compartmental modeling. Patients with PD had significantly higher (P < 0.05) plasma clearance of insulin. In conclusion, these data demonstrate that patients with PD are characterized by increased insulin binding sites associated with an increased insulin sensitivity and clearance rate in comparison with type I insulindependent diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Assessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
Hart, P. A., Bellin, M. D., Andersen, D. K., Bradley, D., Cruz-Monserrate, Z., Forsmark, C. E., Goodarzi, M. O., Habtezion, A., Korc, M., Kudva, Y. C., et al. (2016) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30106-6 · Cited by 551
Pancreatogenic Diabetes: Special Considerations for Management
Cui, Y., & Andersen, D. K. (2011) · Pancreatology · doi:10.1159/000329188 · Cited by 256
Pancreatic Resection: Effects on Glucose Metabolism
Slezak, L. A., & Andersen, D. K. (2001) · World Journal of Surgery · doi:10.1007/s002680020337 · Cited by 254
Metabolic Consequences of (Regional) Total Pancreatectomy
DRESLER, C. M., FORTNER, J. G., MCDERMOTT, K., & BAJORUNAS, D. R. (1991) · Annals of Surgery · doi:10.1097/00000658-199108000-00007 · Cited by 194
Insulin Resistance in Cushing’s Syndrome*
NOSADINI, R., DEL PRATO, S., TIENGO, A., VALERIO, A., MUGGEO, M., OPOCHER, G., MANTERO, F., DUNER, E., MARESCOTTI, C., MOLLO, F., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-3-529 · Cited by 146
Self-citationThe Clinical Outcomes after Total Pancreatectomy
Suzuki, S., Kajiyama, H., Takemura, A., Shimazaki, J., Nishida, K., & Shimoda, M. (2017) · Digestive Surgery · doi:10.1159/000449234 · Cited by 30
Increased nonoxidative glucose metabolism in idiopathic reactive hypoglycemia
Leonetti, F., Foniciello, M., Iozzo, P., Riggio, O., Merli, M., Giovannetti, P., Sbraccia, P., Giaccari, A., & Tamburrano, G. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90031-1 · Cited by 24
Diabetes management in patients undergoing total pancreatectomy: A single center cohort study
Zhao, T., Fu, Y., Zhang, T., Guo, J., Liao, Q., Song, S., Duo, Y., Gao, Y., Yuan, T., & Zhao, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1097139 · Cited by 18
“The lower daily and basal insulin needs in patients following TP may be attributed to increased peripheral insulin sensitivity, malabsorption, and defect in the counterregulatory mechanism offered by pancreatic glucagon (36, 38).”
Background
Metadata
- Authors
- Nosadini, R., Prato, S. D., Tiengo, A., Duner, E., Toffolo, G., Cobelli, C., Faronato, P. P., Moghetti, P., & Muggeo, M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1982-04-01
- Volume
- 31
- Issue
- 4
- Pages
- 346-355
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2046485742
- Cited by
- 79
- References
- 0
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.